Title: Mycoplasma Testing Market Size, Share, Demand, Report, Forecast 2024-2032
1Global Mycoplasma Testing Market Research and
Forecast Report 2024-2032
2023 IMARC All Rights Reserved
2About IMARC Group
- IMARC Group is a global management consulting
firm that helps the worlds most ambitious
changemakers to create a lasting impact. Across
the six major continents and 100 countries, we
work alongside our business partners as one team
with a common ambition to achieve unparallelled
results, gain a competitive edge, and transform
industries. IMARC Group excels in understanding
its clients business priorities and delivering
tailored solutions that drive meaningful
outcomes. Our client base spans over 3,000
organizations in the private, public, and social
sectors, ranging from high-growth startups to
Fortune 500 companies. - We provide a comprehensive suite of market entry
and expansion services. Our offerings include
thorough market assessment, feasibility studies,
company incorporation assistance, factory setup
support, regulatory approvals and licensing
navigation, branding, marketing and sales
strategies, competitive landscape and
benchmarking analyses, pricing and cost research,
and procurement research. These services are
designed to assist companies in evaluating market
opportunities, setting up new entities,
navigating regulatory landscapes, boosting brand
visibility, analyzing competitors, and optimizing
procurement strategies.
3Report Highlight and Description
- According to the latest report by IMARC Group,
titled "Mycoplasma Testing Market Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2024-2032,The global mycoplasma testing
market size reached US 914.9 Million in 2023. - The development of advanced molecular and
microbiological techniques has revolutionized
mycoplasma detection methods, enabling faster,
more sensitive, and more accurate testing
procedures. Polymerase Chain Reaction (PCR),
Deoxyribonucleic acid (DNA) sequencing, and
fluorescence microscopy are among the
cutting-edge technologies utilized for mycoplasma
detection, allowing for rapid identification and
quantification of mycoplasma contaminants in cell
cultures and biopharmaceutical products.
Moreover, the integration of automation and
robotics into testing workflows has streamlined
processes, improved efficiency, and reduced
turnaround times, catering to the demand for
biopharmaceutical manufacturing and quality
control, creating a positive outlook for market
expansion. - Looking forward, IMARC Group expects the market
to reach US 2,388.2 Million by 2032, exhibiting
a growth rate (CAGR) of 11.25 during 2024-2032. - Request for a PDF sample of this report
- https//www.imarcgroup.com/mycoplasma-testing-mark
et/requestsample
4Report Description
- Global Mycoplasma Testing Market Trends
- The growing awareness among researchers and
biopharmaceutical manufacturers about the
potential risks associated with mycoplasma
contamination is contributing to the growth of
the mycoplasma testing market. In line with this,
as the importance of maintaining cell culture
integrity and product quality becomes
increasingly evident, demand for reliable testing
solutions to detect and prevent mycoplasma
contamination continues to rise. Moreover, the
expansion of biopharmaceutical research and
development (RD) activities, coupled with the
increasing globalization of manufacturing
processes, is supporting the growth of the
mycoplasma testing market. - Furthermore, as biopharmaceutical companies
expand their operations globally, the need for
comprehensive mycoplasma testing to ensure
product safety and regulatory compliance is
bolstering the market expansion. - View Report, TOC, Figures and Tables
https//www.imarcgroup.com/mycoplasma-testing-mark
et
5Report Segmentation
- Breakup by Product
- Instruments
- Kits and Reagents
- Services
- Breakup by Technology
- NAAT (Nucleic Acid Amplification Technique)
- ELISA (Enzyme-linked Immunoassay)
- DNA Staining
- Others
6Report Segmentation
- Breakup by Application
- Cell Line Testing
- Virus Testing
- End of Production Cells Testing
- Others
- Breakup by End User
- Academic Research Institutes
- Cell Banks
- Contract Research Organizations
- Pharmaceutical and Biotechnology Companies
- Others
7Report Segmentation
- Breakup by Region
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Australia,
Indonesia, South Korea, Others) - Europe (Germany, France, United Kingdom, Italy,
Spain, Others) - Latin America (Brazil, Mexico, Others)
- Middle East and Africa
8Competitive Landscape
- ATCC
- Bionique Testing Laboratories Inc. (Asahi Kasei
Medical Co. Ltd.) - Bio-Rad Laboratories Inc.
- Charles River Laboratories International Inc.
- Eurofins Scientific SE
- Invivogen
- Lonza Group
- Merck KGaA
- Roche Holding AG
- Sartorius AG
- Thermo Fisher Scientific Inc.
9Key Questions Answered in the Report
10Key Questions Answered in the Report
11Key Questions Answered in the Report
12Table of Contents
1 Preface 2 Scope and Methodology 2.1 Objectives
of the Study 2.2 Stakeholders 2.3 Data
Sources 2.3.1 Primary Sources 2.3.2 Secondary
Sources 2.4 Market Estimation 2.4.1 Bottom-Up
Approach 2.4.2 Top-Down Approach 2.5 Forecasting
Methodology 3 Executive Summary 4 Global
Mycoplasma Testing Market - Introduction 4.1
Overview 4.2 Market Dynamics 4.3 Industry
Trends 4.4 Competitive Intelligence 5 Global
Mycoplasma Testing Market Landscape 5.1
Historical and Current Market Trends
(2018-2023) 5.2 Market Forecast (2024-2032) 6
Global Mycoplasma Testing Market - Breakup by
Product 6.1 Instruments 6.1.1 Overview 6.1.2
Historical and Current Market Trends
(2018-2023) 6.1.3 Market Segmentation 6.1.4
Market Forecast (2024-2032)
13Table of Contents
6.2 Kits and Reagents 6.2.1 Overview 6.2.2
Historical and Current Market Trends
(2018-2023) 6.2.3 Market Segmentation 6.2.4
Market Forecast (2024-2032) 6.3 Services 6.3.1
Overview 6.3.2 Historical and Current Market
Trends (2018-2023) 6.3.3 Market
Segmentation 6.3.4 Market Forecast
(2024-2032) 6.4 Attractive Investment Proposition
by Product 7 Global Mycoplasma Testing Market -
Breakup by Technology 7.1 NAAT (Nucleic Acid
Amplification Technique) 7.1.1 Overview 7.1.2
Historical and Current Market Trends
(2018-2023) 7.1.3 Market Segmentation 7.1.4
Market Forecast (2024-2032) 7.2 ELISA
(Enzyme-linked Immunoassay) 7.2.1 Overview 7.2.2
Historical and Current Market Trends
(2018-2023) 7.2.3 Market Segmentation 7.2.4
Market Forecast (2024-2032) 7.3 DNA
Staining 7.3.1 Overview 7.3.2 Historical and
Current Market Trends (2018-2023) 7.3.3 Market
Segmentation 7.3.4 Market Forecast
(2024-2032) 7.4 Others 7.4.1 Historical and
Current Market Trends (2018-2023) 7.4.2 Market
Forecast (2024-2032)
14Table of Contents
7.5 Attractive Investment Proposition by
Technology 8 Global Mycoplasma Testing Market -
Breakup by Application 8.1 Cell Line
Testing 8.1.1 Overview 8.1.2 Historical and
Current Market Trends (2018-2023) 8.1.3 Market
Segmentation 8.1.4 Market Forecast
(2024-2032) 8.2 Virus Testing 8.2.1
Overview 8.2.2 Historical and Current Market
Trends (2018-2023) 8.2.3 Market
Segmentation 8.2.4 Market Forecast
(2024-2032) 8.3 End of Production Cells
Testing 8.3.1 Overview 8.3.2 Historical and
Current Market Trends (2018-2023) 8.3.3 Market
Segmentation 8.3.4 Market Forecast
(2024-2032) 8.4 Others 8.4.1 Historical and
Current Market Trends (2018-2023) 8.4.2 Market
Forecast (2024-2032) 8.5 Attractive Investment
Proposition by Application 9 Global Mycoplasma
Testing Market - Breakup by End User 9.1 Academic
Research Institutes 9.1.1 Overview 9.1.2
Historical and Current Market Trends
(2018-2023) 9.1.3 Market Segmentation 9.1.4
Market Forecast (2024-2032) 9.2 Cell Banks 9.2.1
Overview 9.2.2 Historical and Current Market
Trends (2018-2023)
15Table of Contents
9.2.3 Market Segmentation 9.2.4 Market Forecast
(2024-2032) 9.3 Contract Research
Organizations 9.3.1 Overview 9.3.2 Historical and
Current Market Trends (2018-2023) 9.3.3 Market
Segmentation 9.3.4 Market Forecast
(2024-2032) 9.4 Pharmaceutical and Biotechnology
Companies 9.4.1 Overview 9.4.2 Historical and
Current Market Trends (2018-2023) 9.4.3 Market
Segmentation 9.4.4 Market Forecast
(2024-2032) 9.5 Others 9.5.1 Historical and
Current Market Trends (2018-2023) 9.5.2 Market
Forecast (2024-2032) 9.6 Attractive Investment
Proposition by End User 10 Global Mycoplasma
Testing Market Breakup by Region 10.1 North
America 10.1.1 United States 10.1.1.1 Market
Drivers 10.1.1.2 Historical and Current Market
Trends (2018-2023) 10.1.1.3 Market Breakup by
Product 10.1.1.4 Market Breakup by
Technology 10.1.1.5 Market Breakup by
Application 10.1.1.6 Market Breakup by End
User 10.1.1.7 Key Players 10.1.1.8 Market
Forecast (2024-2032) 10.1.2 Canada 10.1.2.1
Market Drivers 10.1.2.2 Historical and Current
Market Trends (2018-2023)
16Table of Contents
10.1.2.3 Market Breakup by Product 10.1.2.4
Market Breakup by Technology 10.1.2.5 Market
Breakup by Application 10.1.2.6 Market Breakup by
End User 10.1.2.7 Key Players 10.1.2.8 Market
Forecast (2024-2032) 10.2 Europe 10.2.1
Germany 10.2.1.1 Market Drivers 10.2.1.2
Historical and Current Market Trends
(2018-2023) 10.2.1.3 Market Breakup by
Product 10.2.1.4 Market Breakup by
Technology 10.2.1.5 Market Breakup by
Application 10.2.1.6 Market Breakup by End
User 10.2.1.7 Key Players 10.2.1.8 Market
Forecast (2024-2032) 10.2.2 France 10.2.2.1
Market Drivers 10.2.2.2 Historical and Current
Market Trends (2018-2023) 10.2.2.3 Market Breakup
by Product 10.2.2.4 Market Breakup by
Technology 10.2.2.5 Market Breakup by
Application 10.2.2.6 Market Breakup by End
User 10.2.2.7 Key Players 10.2.2.8 Market
Forecast (2024-2032) 10.2.3 United
Kingdom 10.2.3.1 Market Drivers 10.2.3.2
Historical and Current Market Trends
(2018-2023) 10.2.3.3 Market Breakup by
Product 10. 2.3.4 Market Breakup by
Technology 10. 2.3.5 Market Breakup by Application
17Table of Contents
10. 2.3.6 Market Breakup by End User 10.2.3.7 Key
Players 10.2.3.8 Market Forecast
(2024-2032) 10.2.4 Italy 10.2.4.1 Market
Drivers 10.2.4.2 Historical and Current Market
Trends (2018-2023) 10.2.4.3 Market Breakup by
Product 10.2.4.4 Market Breakup by
Technology 10.2.4.5 Market Breakup by
Application 10.2.4.6 Market Breakup by End
User 10.2.4.7 Key Players 10.2.4.8 Market
Forecast (2024-2032) 10.2.5 Spain 10.2.5.1 Market
Drivers 10.2.5.2 Historical and Current Market
Trends (2018-2023) 10.2.5.3 Market Breakup by
Product 10.2.5.4 Market Breakup by
Technology 10.2.5.5 Market Breakup by
Application 10.2.5.6 Market Breakup by End
User 10.2.5.7 Key Players 10.2.5.8 Market
Forecast (2024-2032) 10.2.6 Others 10.2.6.1
Historical and Current Market Trends
(2018-2023) 10.2.6.2 Market Forecast
(2024-2032) 10.3 Asia Pacific 10.3.1
China 10.3.1.1 Market Drivers 10.3.1.2 Historical
and Current Market Trends (2018-2023) 10.3.1.3
Market Breakup by Product 10.3.1.4 Market Breakup
by Technology 10.3.1.5 Market Breakup by
Application
18Table of Contents
10.3.1.6 Market Breakup by End User 10.3.1.7 Key
Players 10.3.1.8 Market Forecast
(2024-2032) 10.3.2 Japan 10.3.2.1 Market
Drivers 10.3.2.2 Historical and Current Market
Trends (2018-2023) 10.3.2.3 Market Breakup by
Product 10.3.2.4 Market Breakup by
Technology 10.3.2.5 Market Breakup by
Application 10.3.2.6 Market Breakup by End
User 10.3.2.7 Key Players 10.3.2.8 Market
Forecast (2024-2032) 10.3.3 India 10.3.3.1 Market
Drivers 10.3.3.2 Historical and Current Market
Trends (2018-2023) 10.3.3.3 Market Breakup by
Product 10.3.3.4 Market Breakup by
Technology 10.3.3.5 Market Breakup by
Application 10.3.3.6 Market Breakup by End
User 10.3.3.7 Key Players 10.3.3.8 Market
Forecast (2024-2032) 10.3.4 South Korea 10.3.4.1
Market Drivers 10.3.4.2 Historical and Current
Market Trends (2018-2023) 10.3.4.3 Market Breakup
by Product 10.3.4.4 Market Breakup by
Technology 10.3.4.5 Market Breakup by
Application 10.3.4.6 Market Breakup by End
User 10.3.4.7 Key Players 10.3.4.8 Market
Forecast (2024-2032) 10.3.5 Australia
19Table of Contents
10.3.5.1 Market Drivers 10.3.5.2 Historical and
Current Market Trends (2018-2023) 10.3.5.3 Market
Breakup by Product 10.3.5.4 Market Breakup by
Technology 10.3.5.5 Market Breakup by
Application 10.3.5.6 Market Breakup by End
User 10.3.5.7 Key Players 10.3.5.8 Market
Forecast (2024-2032) 10.3.6 Indonesia 10.3.6.1
Market Drivers 10.3.6.2 Historical and Current
Market Trends (2018-2023) 10.3.6.3 Market Breakup
by Product 10.3.6.4 Market Breakup by
Technology 10.3.6.5 Market Breakup by
Application 10.3.6.6 Market Breakup by End
User 10.3.6.7 Key Players 10.3.6.8 Market
Forecast (2024-2032) 10.3.7 Others 10.3.7.1
Historical and Current Market Trends
(2018-2023) 10.3.7.2 Market Forecast
(2024-2032) 10.4 Latin America 10.4.1
Brazil 10.4.1.1 Market Drivers 10.4.1.2
Historical and Current Market Trends
(2018-2023) 10.4.1.3 Market Breakup by
Product 10.4.1.4 Market Breakup by
Technology 10.4.1.5 Market Breakup by
Application 10.4.1.6 Market Breakup by End
User 10.4.1.7 Key Players 10.4.1.8 Market
Forecast (2024-2032) 10.4.2 Mexico
20Table of Contents
10.4.2.1 Market Drivers 10.4.2.2 Historical and
Current Market Trends (2018-2023) 10.4.2.3 Market
Breakup by Product 10.4.2.4 Market Breakup by
Technology 10.4.2.5 Market Breakup by
Application 10.4.2.6 Market Breakup by End
User 10.4.2.7 Key Players 10.4.2.8 Market
Forecast (2024-2032) 10.4.3 Others 10.4.3.1
Historical and Current Market Trends
(2018-2023) 10.4.3.2 Market Forecast
(2024-2032) 10.5 Middle East and Africa 10.5.1
Market Drivers 10.5.2 Historical and Current
Market Trends (2018-2023) 10.5.3 Market Breakup
by Product 10.5.4 Market Breakup by
Technology 10.5.5 Market Breakup by
Application 10.5.6 Market Breakup by End
User 10.5.7 Market Breakup by Country 10.5.8 Key
Players 10.5.9 Market Forecast (2024-2032) 10.6
Attractive Investment Proposition by Region 11
Global Mycoplasma Testing Market Competitive
Landscape 11.1 Overview 11.2 Market
Structure 11.3 Market Share by Key Players 11.4
Market Player Positioning 11.5 Top Winning
Strategies 11.6 Competitive Dashboard 11.7
Company Evaluation Quadrant
21Table of Contents
12 Profiles of Key Players 12.1 ATCC 12.1.1
Business Overview 12.1.2 Product Portfolio 12.1.3
Business Strategies 12.1.4 SWOT Analysis 12.1.5
Major News and Events 12.2 Bionique Testing
Laboratories Inc. (Asahi Kasei Medical Co.
Ltd.) 12.2.1 Business Overview 12.2.2 Product
Portfolio 12.2.3 Business Strategies 12.2.4 SWOT
Analysis 12.2.5 Major News and Events 12.3
Bio-Rad Laboratories Inc. 12.3.1 Business
Overview 12.3.2 Product Portfolio 12.3.3 Business
Strategies 12.3.4 Financials 12.3.5 SWOT
Analysis 12.3.6 Major News and Events 12.4
Charles River Laboratories International
Inc. 12.4.1 Business Overview 12.4.2 Product
Portfolio 12.4.3 Business Strategies 12.4.4
Financials 12.4.5 SWOT Analysis 12.4.6 Major News
and Events 12.5 Eurofins Scientific SE 12.5.1
Business Overview 12.5.2 Product Portfolio 12.5.3
Business Strategies 12.5.4 Financials
22Table of Contents
12.5.5 SWOT Analysis 12.5.6 Major News and
Events 12.6 Invivogen 12.6.1 Business
Overview 12.6.2 Product Portfolio 12.6.3 Business
Strategies 12.6.4 SWOT Analysis 12.6.5 Major News
and Events 12.7 Lonza Group 12.7.1 Business
Overview 12.7.2 Product Portfolio 12.7.3 Business
Strategies 12.7.4 Financials 12.7.5 SWOT
Analysis 12.7.6 Major News and Events 12.8 Merck
KGaA 12.8.1 Business Overview 12.8.2 Product
Portfolio 12.8.3 Business Strategies 12.8.4
Financials 12.8.5 SWOT Analysis 12.8.6 Major News
and Events 12.9 Roche Holding AG 12.9.1 Business
Overview 12.9.2 Product Portfolio 12.9.3 Business
Strategies 12.9.4 Financials 12.9.5 SWOT
Analysis 12.9.6 Major News and Events 12.10
Sartorius AG 12.10.1 Business Overview
23Table of Contents
12.10.2 Product Portfolio 12.10.3 Business
Strategies 12.10.4 Financials 12.10.5 SWOT
Analysis 12.10.6 Major News and Events 12.11
Thermo Fisher Scientific Inc. 12.11.1 Business
Overview 12.11.2 Product Portfolio 12.11.3
Business Strategies 12.11.4 Financials 12.11.5
SWOT Analysis 12.11.6 Major News and Events 13
Global Mycoplasma Testing Market - Industry
Analysis 13.1 Drivers, Restraints, and
Opportunities 13.1.1 Overview 13.1.2
Drivers 13.1.3 Restraints 13.1.4
Opportunities 13.1.5 Impact Analysis 13.2
Porters Five Forces Analysis 13.2.1
Overview 13.2.2 Bargaining Power of
Buyers 13.2.3 Bargaining Power of
Suppliers 13.2.4 Degree of Competition 13.2.5
Threat of New Entrants 13.2.6 Threat of
Substitutes 13.3 Value Chain Analysis 14
Strategic Recommendations 15 Appendix
24Table of Contents
For more information, visit https//www.imarcgrou
p.com/mycoplasma-testing-market/toc
25Partial List of Clients
26Partial List of Clients
27Disclaimer
- 2024 IMARC All Rights Reserved
- This Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting (IMARC). - Disclaimer All contents and data of this
publication, including forecasts, data analysis
and opinion have been based on information and
sources believed to be accurate and reliable at
the time of publishing. International Market
Analysis Research and Consulting makes no
representation of warranty of any kind as to the
accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever
for any loss or damage resulting from opinion,
errors or inaccuracies if any found this
publication. - IMARC, IMARC Group and Global Therapy Insight
Series are registered trademarks of International
Market Analysis Research and Consulting. All
other trademarks used in this publication are
registered trademarks of their respective
companies.
28Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us